Cyclacel Pharmaceuticals Inc (CYCC) — Capital Reinvestment Ratio

Latest as of December 2009: 0.00x

Cyclacel Pharmaceuticals Inc (CYCC) has a Capital Reinvestment Ratio of 0.00x as of December 2009, meaning it reinvests 0% of its operating cash flow ($12.62 Million) in capital expenditures ($2.00K). Check Cyclacel Pharmaceuticals Inc (CYCC) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$12.62 Million

USD

Capital Expenditures

$2.00K

USD

Data as of

Dec 2009

Most recent filing

Annual Capital Reinvestment Ratio for Cyclacel Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Cyclacel Pharmaceuticals Inc from None to None. See CYCC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow